Abstract
Bromocriptine 2.5 mg. twice daily was given to 38 patients with cyclical breast pain and 15 with a non-cyclical pattern in a double blind trial lasting 6 cycles. Response to treatment was assessed by both clinician and patients independently and serum prolactin levels were monitored. Cyclical breast pain was significantly improved by bromocriptine but non-cyclical pain failed to respond. Although most patients were normoprolactinaemic before the trial, bromocriptine therapy produced a significant depression of the mean serum prolactin level.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call